Notícias e Atividades da Silk Road Medical

Silk Road Medical é uma das ...

• Russell 3000;
• TOB Iconic 10,000.

Silk Road Medical é uma empresa listada sob o símbolo SILK (US).

Fusão, aquisição e financiamento envolvendo Silk Road Medical.

• Boston Scientific has announced the acquisition of Silk Road Medical  (publicado em 18 de junho de 2024).

Veja o organograma con seus 22 executivos principais

Biografias mais buscadas da Silk Road Medical

• Chas Mckhann, Chief Executive Officer
• Kevin Ballinger, Director
• Tony Chou, Director

Criar um alerta
para seguir os movimentos de executivos da Silk Road Medical.

Silk Road Medical possui 2.347 concorrentes concorrentes Eurofins (Luxemburgo), Lonza (Suíça) e Johnson & Johnson Innovative Medicine DIA (Estados Unidos).

Popular M&A news in Biotecnologia

• Glycomine acaba de anunciar uma arrecadação de fundos de 115 milhões de dólares. (publicado em 22 de abril de 2025).
• Attovia Therapeutics acaba de anunciar uma arrecadação de fundos de 90 milhões de dólares. (publicado em 21 de abril de 2025).
• Transcarent and Accolade have merged  (publicado em 9 de abril de 2025)..

Outros contatos sugeridos na indústria do Biotecnologia

• Kristina Burow - Director da Scholar Rock
• Steven Gillis - Chairman of the Board da VBI Vaccines
• Ali Behbahani - Non-Executive Director da Adaptimmune Therapeutics

Saiba mais sobre a indústria do Biotecnologia

Últimos comunicados de imprensa de Silk Road Medical

• Silk Road Medical Reports Second Quarter 2022 Financial Results - Silk Road Medical, Inc.
• Silk Road Medical to Report Second Quarter 2022 Financial Results on July 26, 2022 - Silk Road Medical, Inc.
• Silk Road Medical Announces Post Approval Study for the Treatment of Standard Surgical Risk Patients using TCAR - Silk Road Medical, Inc.
• Silk Road Medical Announces Expanded Medicare Coverage for TCAR in Standard Surgical Risk Patients - Silk Road Medical, Inc.
• Silk Road Medical Extends Cash Runway by Securing up to $250 Million in Debt Financing - Silk Road Medical, Inc.
• Silk Road Medical Reports First Quarter 2022 Financial Results - Silk Road Medical, Inc.
• Silk Road Medical Announces FDA Approval of Expanded Indications for the ENROUTE® Transcarotid Stent System - Silk Road Medical, Inc.
• Silk Road Medical to Present at the BofA Securities 2022 Healthcare Conference - Silk Road Medical, Inc.
• Silk Road Medical to Report First Quarter 2022 Financial Results on May 4, 2022 - Silk Road Medical, Inc.
• Silk Road Medical Reports Fourth Quarter and Full Year 2021 Financial Results and Provides 2022 Financial Outlook - Silk Road Medical, Inc.
• View more press releases Close

Redes sociais sobre Silk Road Medical

• Silk Road Medical na Wikipedia, Google News e Yahoo Finance
• Silk Road Medical na LinkedIn, Twitter e YouTube